ISDSF yields 20000.00% · PFE yields 6.13%● Live data
📍 ISDSF pulled ahead of the other in Year 1
Combined, ISDSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ISDSF + PFE for your $10,000?
iSIGN Media Solutions Inc., a data-focused software-as-a-service company, provides location-based security alert messaging and proximity marketing solutions in North America. The company provides Hybrid Analytics Location Observation, a software platform and listening device that offers a suite of functions specifically designed to maximize safety and security within a managed environment, such as school, hospital, shopping plaza, and concert venue; Hybrid Analytics Location Observation with facial recognition offers facial and object recognition modules; Passive Historical Aggregate Contact Tracing, an intelligent smart space analytics platform that utilizes publicly available anonymous interactions between mobile devices to accurately determine occupancy levels and movements of individuals. It offers InHome Care, a virtual intelligent in-home health care solution; and Smart Antenna solutions. In addition, it provides data management/broadcasting of commercial messaging and security alert messaging; purchases, sells, and leases hardware.; license agreements for the integration of hardware and technology into other companies' hardware; and data and analytic sales solutions. It serves advertisers, manufacturers, retailers, and advertising agencies. iSIGN Media Solutions Inc. was incorporated in 2007 and is headquartered in Richmond Hill, Canada.
Full ISDSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.